The new study, presented at the American Academy of Pain Medicine’s annual meeting, shows that patients’ response to intraarticular sacroiliac steroid injections was not an accurate predictor of their subsequent responses to radiofrequency ablation treatment.
Patients with less than 50 perfect pain relief following the injections should not be disqualified from receiving radiofrequency ablation treatment, the study concluded.
Related Articles on Pain Management:
Chronic Pain Can be Measured With Bar Code, Researchers Say
5 Pain Management Physicians on Epidural Steroid Injections for Pain Treatment
Low Dose of Naltexone Reduces Pain in Fibromyalia Patients, Study Finds
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.